CompuGroup Medical SE/ DE000A288904 /
| 2024-07-05 3:46:08 PM | Chg. - | Volume | Bid9:00:15 AM | Ask9:00:15 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 23.82EUR | - | 139 Turnover: 3,310.98 |
-Bid Size: - | -Ask Size: - | 721.89 mill.EUR | 7.24% | 15.70 |
Assets
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 83.7000 | 88.1000 | 91.8000 | 100.1000 | 107.5000 | ||||||
| Intangible Assets | 536.5000 | 668.3000 | 1,088.1000 | 1,214.3000 | 1,293.9000 | ||||||
| Long-Term Investments | 12 | 11.4000 | 12.9000 | 24.5000 | 65.2000 | ||||||
| Fixed Assets | - | - | - | - | 1,523.6000 | ||||||
| Inventories | 19.6000 | 27.5000 | 18.2000 | 20.6000 | 29.4000 | ||||||
| Accounts Receivable | 111.4000 | 103 | 137.2000 | 147.2000 | 189.4000 | ||||||
| Cash and Cash Equivalents | 25.3000 | 46.4000 | 75.9000 | 107.3000 | 90.5000 | ||||||
| Current Assets | 191.8000 | 232.9000 | 308.1000 | 370.8000 | 420.8000 | ||||||
| Total Assets | 848.3000 | 1,065.9000 | 1,565.8000 | 1,790.8000 | 1,944.4000 | ||||||
Liabilities
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 39.3000 | 47.1000 | 64.5000 | 93.2000 | 112.6000 | ||||||
| Long-term debt | 319.7000 | 424.5000 | 470.2000 | 587.1000 | 733.1000 | ||||||
| Liabilities to Banks | 337.1000 | 471.2000 | 515.3000 | 694.7000 | - | ||||||
| Provisions | 100 | 130.8000 | 149.5000 | 170.8000 | 201.8000 | ||||||
| Liabilities | 575.3000 | 805.9000 | 926.8000 | 1,192.1000 | 1,944.4000 | ||||||
| Share Capital | 53.2190 | 53.2190 | 53.7350 | 53.7350 | - | ||||||
| Total Equity | 273 | 259.9000 | 638.9000 | 612.3000 | 672.4000 | ||||||
| Minority Interests | 2.1000 | .8000 | .3000 | .2000 | 1.4000 | ||||||
| Total liabilities equity | 848.3000 | 1,065.9000 | 1,565.8000 | 1,790.8000 | 1,944.4000 | ||||||
Income Statement
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 717 | 745.8000 | 837.3000 | 1,025.3000 | 1,129.7000 | ||||||
| Depreciation (total) | 44.6000 | 62.9000 | 75.5000 | 110.7000 | 112.4000 | ||||||
| Operating Result | 137.9000 | 115.3000 | 121.8000 | 102.7000 | 104 | ||||||
| Interest Income | -8.8000 | -5.7000 | -10.4000 | -4.8000 | 8.1000 | ||||||
| Income Before Taxes | 128.8000 | 107.7000 | 110.4000 | 97.9000 | - | ||||||
| Income Taxes | 36.2000 | 41.6000 | 37 | 28.8000 | 32.7000 | ||||||
| Minority Interests Profit | -.3000 | -.3000 | -.2000 | -.0600 | -.0700 | ||||||
| Net Income | 92.3000 | 65.8000 | 73.2000 | 69 | 73.4000 | ||||||
Per Share
Cash Flow
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 136.3000 | 110.5000 | 149.9000 | 165.3000 | 145 | ||||||
| Cash Flow from Investing Activities | -47.5000 | -139.4000 | -457.1000 | -164 | -145.4000 | ||||||
| Cash Flow from Financing | -93.4000 | 49.7000 | 338.1000 | 30.2000 | -16.4000 | ||||||
| Decrease / Increase in Cash | -4.5000 | 20.7000 | 30.9000 | 31.5000 | - | ||||||
| Employees | 4,955 | 5,627 | 7,814 | 8,598 | 9,229 | ||||||
